Background illustration for clinical trials search

Paid Clinical Trials New Braunfels

Discover 1,413 paid clinical trials in New Braunfels, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

for
Chronic Kidney Disease
Location: San Antonio TX, El Paso TX, Kansas City MO,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT06717698

Phase2, Recruiting

Phase 3 Efficacy and Safety Study of VVZ-149 Injections for Postoperative Pain Following Bunionectomy

for
Pain, Postoperative
Location: San Antonio TX, Phoenix AZ, Anaheim CA
Sponsor: Vivozon, Inc.

Sex: All

Age: 18+

Code: NCT04430088

Phase3, Recruiting

Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency

for
Limbal Stem Cell Deficiency
Location: San Antonio TX, Overland Park KS, Smyrna TN,
Sponsor: Claris Biotherapeutics, Inc.

Sex: All

Age: 12 - 70+

Code: NCT07636590

Recruiting

Ketones, SGLT2, HFrEF

for
Type2diabetes, Heart Failure With Reduced Ejection Fraction
Location: San Antonio TX
Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All

Age: 18 - 70

Code: NCT06229678

Early_phase1, Recruiting

SGLTi, Hepatic Glucose Production and Ketogenesis

for
Type 2 Diabetes
Location: San Antonio TX
Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All

Age: 30 - 70+

Code: NCT05960656

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants

for
Type 2 Diabetes Mellitus in Obese,
Location: San Antonio TX
Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All

Age: 30 - 70

Code: NCT05838287

Recruiting

SGLT2i, Pioglitazone, and Ketone Production in T2D

for
Type 2 Diabetes
Location: San Antonio TX
Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All

Age: 30 - 70+

Code: NCT07053319

Phase1, Recruiting

SGLT2i, Hepatic Glucose Production, and SNS

for
Type 2 Diabetes
Location: San Antonio TX
Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All

Age: 30 - 70+

Code: NCT07053293

Early_phase1, Recruiting

Image-guided, Robot Navigated Transcranial Magnetic Stimulation (IR-TMS) for Alcohol Use Disorder (AUD)

for
Alcohol Use Disorder
Location: San Antonio TX
Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All

Age: 18 - 65

Code: NCT06648642

Recruiting

Neural Connectivity During Therapy for Adolescent PTSD

for
PTSD, Adolescent, Psychological Trauma
Location: San Antonio TX
Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All

Age: 12 - 17

Code: NCT05423444

Recruiting

TMS for PTSD in Youth

for
Post Traumatic Stress Disorder (PTSD)
Location: San Antonio TX
Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All

Age: 12 - 20

Code: NCT07401225

Recruiting

Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

for
Schizophrenia
Location: San Antonio TX, Richmond TX, Houston TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07379827

Recruiting

A Phase 2 Study to Evaluate the Pharmacodynamics, Safety and Tolerability of BGE-102 in Participants With Obesity and Cardiovascular Risk Factors

for
Obesity and Cardiovascular Risk
Location: San Antonio TX, Austin TX, Rogers AR, Kansas City MO,
Sponsor: BioAge Labs, Inc.

Sex: All

Age: 18+

Code: NCT07656727

Phase2, Recruiting

A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo

for
Vitiligo, Non-Segmental Vitiligo (NSV)
Location: San Antonio TX, Humble TX, Phoenix AZ, Sandy Springs GA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07533019

Phase2, Recruiting

To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With Locally Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic Solid Tumors
Location: San Antonio TX, Houston TX, Oklahoma City OK,
Sponsor: Day One Biopharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06752681

Phase1, Recruiting

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

for
Solid Tumors
Location: San Antonio TX, Houston TX, Dallas TX, Denison TX,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07522073

Phase3, Recruiting

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

for
Multiple Myeloma, Newly Diagnosed Multiple Myeloma
Location: San Antonio TX, Austin TX, Kingwood TX, Tyler TX,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06679101

Phase3, Recruiting

A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease

for
Proteinuric Kidney Disease
Location: San Antonio TX, Houston TX, Shenandoah TX, Dallas TX,
Sponsor: Maze Therapeutics

Sex: All

Age: 18 - 68

Code: NCT06830629

Phase2, Recruiting

A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting

for
Ulcerative Colitis, Crohn's Disease
Location: Lubbock TX, Georgetown TX, Waco TX, Katy TX, Houston TX,
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT06581328

Recruiting

Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment

for
Eosinophilic Asthma
Location: San Antonio TX, McKinney TX, Oklahoma City OK,
Sponsor: AstraZeneca

Sex: All

Age: 12 - 70+

Code: NCT06750289

Phase3, Recruiting